Buy Stocks Easy | About Us
October 26, 2021
Buy Stocks Easy | Online Stocks

FGEN


Buy FibroGen, Inc Stock (symbol: FGEN) Easy Online

Company Name: FibroGen, Inc

Symbol: FGEN

Sector: Health Care

Industry: Major Pharmaceuticals

IPO: 2014

FGEN Current Share Price

Today's FGEN ( FibroGen, Inc ) opening price: $

Yesterday's FGEN ( FibroGen, Inc ) closing price: $

FibroGen, Inc Stock ( symbol: FGEN ) Price Chart since IPO (2014):

12 Months FibroGen, Inc Stock ( symbol: FGEN ) Price Chart

Popular Questions about FibroGen, Inc Public Stock ( FGEN )

A: FibroGen, Inc stock symbol (also called stock or share ticker) is FGEN

A: FibroGen, Inc IPO (Initial Public Offering) took place on 2014

A: FibroGen, Inc's stock (FGEN symbol) price at ther IPO (initial Public Offering) was $

Q: Is FGEN stock worth buying at the moment?

A: The FGEN stock performance since 2019 are rather disappointing. If you had bought 1 share of FibroGen, Inc stock (symbol: FGEN) at the beginning of 2019, at the opening share price of $56.7500, you would be left with exactly $ - which means a waste of your money and time. - SHOW ONLY IF equal or loose.

Buy FibroGen, Inc Stock Easy Online

FibroGen, Inc Stock Ticker Price Chart since IPO:





FibroGen, Inc Stock Price Yesterday



 


FibroGen, Inc Stock Price – Last Week




 


FibroGen, Inc Stock Price – Last Month




 


FibroGen, Inc Stock Value Chart – 12 Months




            

                

                    

                    
                

                
                
Rate this post

                
            

            
            

             

            

        

    



            



    

        

            

                
 Latest Stock News: 

            

        

        



                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/12/02/1954627/0/en/FibroGen-Announces-Roxadustat-Inclusion-in-China-s-National-Reimbursement-Drug-List.html
                            

                                
FibroGen Announces Roxadustat Inclusion in China’s National Reimbursement Drug List

                                
                                
SAN FRANCISCO, Dec.  02, 2019  (GLOBE NEWSWIRE) -- FibroGen, Inc. (...


                            

                        
                    

                


                            

                    


                        
                            https://seekingalpha.com/article/4306071-fibrogen-inc-fgen-ceo-james-schoeneck-q3-2019-results-earnings-call-transcript
                            

                                
FibroGen, Inc. (FGEN) CEO James Schoeneck on Q3 2019 Results - Earnings Call Transcript

                                
                                
FibroGen, Inc. (FGEN) CEO James Schoeneck on Q3 2019 Results - Earn...


                            

                        
                    

                


                            

                    


                        
                            https://seekingalpha.com/article/4305714-fibrogen-overcomes-safety-hurdle-clear-path-towards-fda-approval-ckd-patients
                            

                                
FibroGen Overcomes Safety Hurdle; Clear Path Towards FDA Approval For CKD Patients

                                
                                
FibroGen Overcomes Safety Hurdle; Clear Path Towards FDA Approval F...


                            

                        
                    

                


                            

                    


                        
                            http://www.zacks.com/stock/news/614805/fibrogen-fgen-reports-q3-loss-tops-revenue-estimates
                            

                                
FibroGen (FGEN) Reports Q3 Loss, Tops Revenue Estimates

                                
                                
FibroGen (FGEN) delivered earnings and revenue surprises of 3.39% a...


                            

                        
                    

                


                            

                    


                        
                            https://www.fool.com/investing/2019/11/11/heres-why-fibrogens-stock-popped-friday.aspx
                            

                                
Here’s Why FibroGen’s Stock Popped Friday

                                
                                
FibroGen reported highly anticipated clinical data on Friday for it...


                            

                        
                    

                


                            

                    


                        
                            http://www.zacks.com/stock/news/614208/fibrogen-fgen-soars-stock-adds-96-in-session
                            

                                
FibroGen (FGEN) Soars: Stock Adds 9.6% in Session

                                
                                
FibroGen (FGEN) saw a big move last session, as its shares jumped n...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/11/08/1944228/0/en/FibroGen-Announces-Positive-Phase-3-Pooled-Roxadustat-Safety-and-Efficacy-Results-for-Treatment-of-Anemia-in-Chronic-Kidney-Disease.html
                            

                                
FibroGen Announces Positive Phase 3 Pooled Roxadustat Safety and Efficacy Results for Treatment of Anemia in Chronic Kidney Disease

                                
                                
Roxadustat cardiovascular safety comparable to placebo in non-dialy...


                            

                        
                    

                


                            

                    


                        
                            https://seekingalpha.com/article/4302160-next-big-biotech-blow
                            

                                
The Next Big Biotech Blow-Up

                                
                                
The Next Big Biotech Blow-Up


                            

                        
                    

                


                            

                    


                        
                            http://www.zacks.com/stock/news/594868/5-stocks-with-high-net-income-ratio-to-grab-now
                            

                                
5 Stocks With High Net Income Ratio to Grab Now

                                
                                
Investors always have a keen eye for companies having a high level ...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/10/23/1933981/0/en/FibroGen-Announces-First-Patient-Dosed-in-LAPIS-a-Phase-3-Clinical-Trial-of-Pamrevlumab-for-the-Treatment-of-Patients-With-Locally-Advanced-Pancreatic-Cancer.html
                            

                                
FibroGen Announces First Patient Dosed in LAPIS, a Phase 3 Clinical Trial of Pamrevlumab for the Treatment of Patients With Locally Advanced Pancreatic Cancer  

                                
                                
SAN FRANCISCO, Oct.  23, 2019  (GLOBE NEWSWIRE) -- FibroGen, Inc. (...


                            

                        
                    

                


            
        

    




    
    





	
	  

	  All right reserved Buy Stocks Easy , 2019.